PRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANI’s Nitazoxanide Tablets ...
ANI Pharmaceuticals, Inc. announced the launch of its Prucalopride Tablets, a generic version of the drug Motegrity®, following final FDA approval of their Abbreviated New Drug Application. The new ...
Tablets were first developed in the mid-1850s, during which sugar coating (SC) was primarily used to improve their surface characteristics and protect pharmaceutical agents from the harsh environment ...
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and ...
Barr Pharmaceuticals and Duramed Pharmaceutical's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Tablets Receives Two New FDA Approvals WOODCLIFF LAKE, N.J., April 30 -- Duramed Pharmaceuticals, Inc.
The European Bank for Reconstruction and Development (EBRD) is promoting further growth in domestic production of ...
Pharmaceuticals are developed, designed, and commonly manufactured in laboratory settings. Laboratory testing is an essential need in almost every stage of pharmaceutical production and R&D, from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback